110 related articles for article (PubMed ID: 17454044)
1. In vitro antimicrobial effect of encapsulated vancomycin on internalized Staphylococcus aureus within endothelial cells.
Nettey H; Haswani D; D'Souza M; Oettinger C
Drug Dev Ind Pharm; 2007 Feb; 33(2):133-9. PubMed ID: 17454044
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation and targeting of E. coli internalized by endothelial cells using albumin microspheres loaded with gentamicin.
Haswani DK; Nettey H; D'Souza MJ; Oettinger CW
Drug Dev Ind Pharm; 2007 Feb; 33(2):181-90. PubMed ID: 17454050
[TBL] [Abstract][Full Text] [Related]
3. Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying.
Nettey H; Haswani D; Oettinger CW; D'Souza MJ
J Microencapsul; 2006 Sep; 23(6):632-42. PubMed ID: 17118879
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying.
Booysen E; Bezuidenhout M; van Staden ADP; Dimitrov D; Deane SM; Dicks LMT
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):310-316. PubMed ID: 29961212
[TBL] [Abstract][Full Text] [Related]
5. Demineralized bone matrix paste formulated with biomimetic PLGA microcarriers for the vancomycin hydrochloride controlled delivery: Release profile, citotoxicity and efficacy against S. aureus.
Govoni M; Lamparelli EP; Ciardulli MC; Santoro A; Oliviero A; Palazzo I; Reverchon E; Vivarelli L; Maso A; Storni E; Donati ME; Ruspaggiari G; Maffulli N; Fini M; Della Porta G; Dallari D
Int J Pharm; 2020 May; 582():119322. PubMed ID: 32298742
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic polyelectrolyte-vitamin C nanoparticulate system in polyvinyl alcohol-alginate hydrogel: An approach to treat skin and soft tissue infections caused by Staphylococcus aureus.
George L; Bavya MC; Rohan KV; Srivastava R
Colloids Surf B Biointerfaces; 2017 Dec; 160():315-324. PubMed ID: 28950196
[TBL] [Abstract][Full Text] [Related]
7. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide.
Zhang W; Taheri-Ledari R; Hajizadeh Z; Zolfaghari E; Ahghari MR; Maleki A; Hamblin MR; Tian Y
Nanoscale; 2020 Feb; 12(6):3855-3870. PubMed ID: 31996884
[TBL] [Abstract][Full Text] [Related]
8. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
10. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
11. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity.
Kaur A; Preet S; Kumar V; Kumar R; Kumar R
Colloids Surf B Biointerfaces; 2019 Apr; 176():62-69. PubMed ID: 30594704
[TBL] [Abstract][Full Text] [Related]
12. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.
Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium.
Mercier RC; Stumpo C; Rybak MJ
J Antimicrob Chemother; 2002 Jul; 50(1):19-24. PubMed ID: 12096002
[TBL] [Abstract][Full Text] [Related]
14. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
Chakraborty SP; Sahu SK; Mahapatra SK; Santra S; Bal M; Roy S; Pramanik P
Nanotechnology; 2010 Mar; 21(10):105103. PubMed ID: 20154376
[TBL] [Abstract][Full Text] [Related]
15. Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.
Geisel R; Schmitz FJ; Fluit AC; Labischinski H
Eur J Clin Microbiol Infect Dis; 2001 Oct; 20(10):685-97. PubMed ID: 11757969
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive and Highly Selective Detection of
Ma Y; Lin X; Xue B; Luan D; Jia C; Feng S; Bian X; Zhao J
Anal Chem; 2024 May; 96(21):8641-8647. PubMed ID: 38716697
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
[TBL] [Abstract][Full Text] [Related]
18. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms.
Jefferson KK; Goldmann DA; Pier GB
Antimicrob Agents Chemother; 2005 Jun; 49(6):2467-73. PubMed ID: 15917548
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
20. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
